Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

Clinical trial NCT07223424 · RECRUITING

Trial details

NCT number: NCT07223424
Sponsor: Diwakar Davar
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma Non Small Cell Lung Cancer Melanoma Colo-rectal Cancer (dMMR/MSI-H CRC)Hepatocellular Carcinoma Ulcerative Colitis Esophageal Cancer Squamous Cell Carcinoma Gastric/GEJ Cervical Cancer Gastro-Esophageal Adenocarcinoma Esophageal Adenocarcinoma

Start date: 2025-11-04
Primary completion: 2030-11-30
Enrollment: 880

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.